182 related articles for article (PubMed ID: 9353843)
1. Aspirin for the second hundred years: new uses for an old drug.
Vainio H; Morgan G
Pharmacol Toxicol; 1997 Oct; 81(4):151-2. PubMed ID: 9353843
[TBL] [Abstract][Full Text] [Related]
2. The aspirin story - from willow to wonder drug.
Desborough MJR; Keeling DM
Br J Haematol; 2017 Jun; 177(5):674-683. PubMed ID: 28106908
[TBL] [Abstract][Full Text] [Related]
3. [A 100 years of aspirin: a drug with a future?].
Sánchez García P
An R Acad Nac Med (Madr); 1997; 114(1):157-63; discussion 164-7. PubMed ID: 9324911
[No Abstract] [Full Text] [Related]
4. COX-2 selective NSAIDs.
Ryan NS
Cleve Clin J Med; 2000 Jan; 67(1):67. PubMed ID: 10645679
[No Abstract] [Full Text] [Related]
5. Aspirin and cyclooxygenase-2 inhibitors.
Armstrong TA
Am J Health Syst Pharm; 2003 Jul; 60(14):1481. PubMed ID: 12892035
[No Abstract] [Full Text] [Related]
6. [A short history of anti-rheumatic therapy. II. Aspirin].
Pasero G; Marson P
Reumatismo; 2010; 62(2):148-56. PubMed ID: 20657891
[TBL] [Abstract][Full Text] [Related]
7. [Indications for aspirin on the centennial of its discovery].
Moreno González A
An R Acad Nac Med (Madr); 1997; 114(4):765-70. PubMed ID: 9616942
[No Abstract] [Full Text] [Related]
8. Cardioprotective effects of aspirin compromised by other NSAIDs.
Gottlieb S
BMJ; 2003 Sep; 327(7414):520. PubMed ID: 12958094
[No Abstract] [Full Text] [Related]
9. The mechanism of action of aspirin.
Vane JR; Botting RM
Thromb Res; 2003 Jun; 110(5-6):255-8. PubMed ID: 14592543
[TBL] [Abstract][Full Text] [Related]
10. The first 3500 years of aspirin history from its roots - A concise summary.
Montinari MR; Minelli S; De Caterina R
Vascul Pharmacol; 2019 Feb; 113():1-8. PubMed ID: 30391545
[TBL] [Abstract][Full Text] [Related]
11. The fight against rheumatism: from willow bark to COX-1 sparing drugs.
Vane JR
J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):573-86. PubMed ID: 11192932
[TBL] [Abstract][Full Text] [Related]
12. What are all the things that aspirin does?
Flower R
BMJ; 2003 Sep; 327(7415):572-3. PubMed ID: 12969898
[No Abstract] [Full Text] [Related]
13. Aspirin: new cardiovascular uses for an old drug.
Patrono C
Am J Med; 2001 Jan; 110(1A):62S-65S. PubMed ID: 11166001
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular events and COX-2 inhibitors.
McGeer PL; McGeer EG; Yasojima K
JAMA; 2001 Dec; 286(22):2810; author reply 2811-2. PubMed ID: 11735747
[No Abstract] [Full Text] [Related]
15. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):294-305. PubMed ID: 11769881
[TBL] [Abstract][Full Text] [Related]
16. [From willow bark to acetylsalicylic acid].
Norn S; Permin H; Kruse PR; Kruse E
Dan Medicinhist Arbog; 2009; 37():79-98. PubMed ID: 20509453
[TBL] [Abstract][Full Text] [Related]
17. High on treatment platelet reactivity against aspirin by non-steroidal anti-inflammatory drugs--pharmacological mechanisms and clinical relevance.
Hohlfeld T; Saxena A; Schrör K
Thromb Haemost; 2013 May; 109(5):825-33. PubMed ID: 23238666
[TBL] [Abstract][Full Text] [Related]
18. Aspirin resistance: does it exist and is it an important clinical problem?
Eikelboom J
Clin Adv Hematol Oncol; 2006 Apr; 4(4):268-70. PubMed ID: 16728937
[No Abstract] [Full Text] [Related]
19. [Aspirin, pain and inflammation].
Vergne P; Bertin P; Trèves R
Rev Med Interne; 2000 Mar; 21 Suppl 1():89s-96s. PubMed ID: 10763210
[TBL] [Abstract][Full Text] [Related]
20. [Aspirin and prevention of cardiovascular risk].
Karila-Cohen D; Gabriel Steg P
Rev Med Interne; 2000 Mar; 21 Suppl 1():35s-40s. PubMed ID: 10763203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
